Wilmington Funds Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	$283K	Sell	12,537 -4,230	-25%	-$95.5K	0.03%	550
2014 Q1	$408K	Sell	16,767 -9,976	-37%	-$243K	0.04%	425
2013 Q4	$668K	Buy	26,743 +363	+1%	+$9.07K	0.07%	320
2013 Q3	$725K	Buy	+26,380	New	+$725K	0.07%	285